MENU
+Compare
NVO
Stock ticker: NYSE
AS OF
May 8 closing price
Price
$64.85
Change
-$2.70 (-4.00%)
Capitalization
301.75B

NVO Novo-Nordisk A/S Forecast, Technical & Fundamental Analysis

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world... Show more

NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for NVO with price predictions
May 07, 2025

NVO's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for NVO turned positive on April 23, 2025. Looking at past instances where NVO's MACD turned positive, the stock continued to rise in of 56 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NVO's RSI Oscillator exited the oversold zone, of 16 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 30, 2025. You may want to consider a long position or call options on NVO as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NVO advanced for three days, in of 327 cases, the price rose further within the following month. The odds of a continued upward trend are .

NVO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NVO entered a downward trend on April 30, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (13.514) is normal, around the industry mean (14.238). P/E Ratio (19.308) is within average values for comparable stocks, (62.770). Projected Growth (PEG Ratio) (0.985) is also within normal values, averaging (1.866). Dividend Yield (0.024) settles around the average of (0.024) among similar stocks. P/S Ratio (6.716) is also within normal values, averaging (252.967).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. NVO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NVO is expected to report earnings to fall 86.00% to 91 cents per share on August 06

Novo-Nordisk A/S NVO Stock Earnings Reports
Q2'25
Est.
$0.91
Q1'25
Beat
by $5.64
Q4'24
Beat
by $5.46
Q3'24
Beat
by $5.24
Q2'24
Beat
by $9.46
The last earnings report on May 07 showed earnings per share of $6.53, beating the estimate of 89 cents. With 12.05M shares outstanding, the current market capitalization sits at 301.75B.
A.I.Advisor
published Dividends

NVO paid dividends on April 08, 2025

Novo-Nordisk A/S NVO Stock Dividends
А dividend of $1.10 per share was paid with a record date of April 08, 2025, and an ex-dividend date of March 31, 2025. Read more...
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UBSI35.820.79
+2.26%
United Bankshares
ALLK0.33N/A
+0.06%
Allakos
GROY1.55N/A
N/A
Gold Royalty Corp
D55.00-0.15
-0.27%
Dominion Energy
CCEC20.05-0.06
-0.30%
Capital Clean Energy Carriers Corp

NVO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NVO has been closely correlated with NONOF. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if NVO jumps, then NONOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVO
1D Price
Change %
NVO100%
-4.00%
NONOF - NVO
70%
Closely correlated
-3.03%
BCAB - NVO
37%
Loosely correlated
+5.58%
TECH - NVO
35%
Loosely correlated
+2.11%
IONS - NVO
31%
Poorly correlated
-0.97%
GALT - NVO
30%
Poorly correlated
-10.83%
More

Groups containing NVO

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVO
1D Price
Change %
NVO100%
-4.00%
Pharmaceuticals
category (304 stocks)
23%
Poorly correlated
+0.15%